The Safety Controls IPO is a ₹48 crore book-built issue, consisting entirely of a fresh…
Speciality Medicines IPO Sees Flat GMP and Cautious Investor Mood
The Speciality Medicines IPO has started attracting attention in the SME segment, and many investors are now tracking its Grey Market Premium (GMP) to understand the possible listing performance.
Let’s break it down in a simple way. GMP is the extra price at which IPO shares are traded unofficially before they get listed on the stock exchange. It helps investors get an early idea of demand and expected listing gains.
Speciality Medicines IPO GMP
| Date | IPO GMP | GMP Trend | Gain |
|---|---|---|---|
| 23 March | ₹- | – | -% |
| 21 March | ₹- | – | -% |
| 20 March | ₹- | – | -% |
| 19 March | ₹- | – | -% |
As per the latest updates, the GMP for Speciality Medicines IPO is currently around ₹0, which means there is no strong activity in the grey market right now.
This suggests a neutral sentiment among investors, where neither strong demand nor negative pressure is clearly visible.
The IPO opened on 20 March 2026 and will remain open for subscription till 24 March 2026.
It is an SME IPO and is entirely a fresh issue, meaning the company is raising funds for its business rather than offering shares from existing investors.
Speciality Medicines IPO Details
| IPO Open Date | March 20, 2026 |
| IPO Close Date | March 24, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹117 to ₹124 Per Share |
| Issue Size | Approx ₹29.14 Crores |
| Fresh Issue | Approx ₹29.14 Crores |
| Issue Type | Book build Issue |
| IPO Listing | BSE SME |
The price band has been set in a reasonable range, making it accessible for investors who are interested in SME IPO opportunities. The company operates in the pharmaceutical segment, focusing on speciality medicines, which is a growing sector in India.
Another important point is that a flat GMP (₹0) usually indicates a “wait and watch” approach in the market. Investors are likely waiting for subscription data or more clarity before showing strong interest.
Speciality Medicines IPO Dates
| IPO Open Date: | March 20, 2026 |
| IPO Close Date: | March 24, 2026 |
| Basis of Allotment: | March 25, 2026 |
| Refunds: | March 27, 2026 |
| Credit to Demat Account: | March 27, 2026 |
| IPO Listing Date: | March 30, 2026 |
However, it’s important to remember that GMP is not an official number. It can change daily depending on market mood, demand, and overall sentiment. Sometimes IPOs with low GMP still perform well after listing, while high GMP does not always guarantee profits.
In conclusion, the Speciality Medicines IPO currently shows neutral grey market signals. If you are planning to invest, it’s better to also look at the company’s fundamentals, growth potential, and long-term outlook instead of relying only on GMP.
👉 Smart investing is always about the bigger picture—not just grey market trends.
Related Posts
